Drawing for VANTIVE

USPTO serial 98097932

VANTIVE

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ADEJUNMOBI, AKIN T
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with VANTIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KATHERINE ALLOR

510 Lake Cook RoadDEERFIELD, IL 60015United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for the control, monitoring and management of dialysis treatment sessions, for managing and analyzing dialysis patient data and dialysis treatment protocols, and for detecting and displaying dialysis treatment parameters; downloadable software for creating and updating specific operating modes for dialysis machines; downloadable software in the nature of a mobile application to facilitate communication, namely, allowing patients and healthcare professionals to access, collect and share information, vital signs and other health information in the treatment of kidney disease; downloadable software in the nature of a mobile application that enables users to receive medical diagnosis and consultation, prescription management, and medical device and therapy training in the treatment of kidney disease; downloadable computer software and mobile application for diagnosing hardware issues, analyzing operational parameters of equipment, analyzing installed applications, remotely locating equipment and recovery capabilitiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2026EX4GSOU EXTENSION 4 GRANTED—
Sep 29, 2026EXT4SOU EXTENSION 4 FILED—
Sep 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 26, 2026EX3GSOU EXTENSION 3 GRANTED—
Mar 26, 2026EXT3SOU EXTENSION 3 FILED—
Mar 26, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 16, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 15, 2025EX2GSOU EXTENSION 2 GRANTED—
Sep 15, 2025EXT2SOU EXTENSION 2 FILED—
Sep 15, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2025EX1GSOU EXTENSION 1 GRANTED—
Mar 20, 2025EXT1SOU EXTENSION 1 FILED—
Mar 20, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 25, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 10, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 10, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 10, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 9, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 7, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 7, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 7, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 6, 2024DOCKASSIGNED TO EXAMINER—
Aug 22, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 27, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance